Terns Pharmaceuticals News

Express News | Vir Biotech rose by 19.66%, while novavax rose by 18.07%. Terns Pharmaceuticals, protagonist therapeutics, pacific biosciences of california, adaptive biotechnologies all rose by 16.84-13.27%. Avadel Pharmaceuticals Plc. dropped 3.82% and performed third

BreakingsJun 5 16:06

Wall Street Analysts Believe Terns Pharmaceuticals (TERN) Could Rally 136.44%: Here's Is How to Trade

Yahoo FinanceJun 4 08:55

Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)

FOSTER CITY, Calif., June 03, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. ("Terns" or the "Company") (NASDAQ:TERN), a clinical-stage biopharmaceutical company developing a portfolio of small molecule product

GlobeNewswireJun 3 15:10

Buy Rating Upheld for Terns Pharmaceuticals Amid Strong Prospects for TERN-701 and Financial Stability

TipRanksJun 2 15:45

Terns Pharmaceuticals to Participate in Upcoming June Investor Conferences

FOSTER CITY, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. ("Terns" or the "Company") (NASDAQ:TERN), a clinical-stage biopharmaceutical company developing a portfolio of small molecule product

GlobeNewswireMay 30 07:05

Terns Pharmaceuticals to Participate in UBS Obesity Therapeutics Day

FOSTER CITY, Calif., May 17, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. ("Terns" or the "Company") (NASDAQ:TERN), a clinical-stage biopharmaceutical company developing a portfolio of small molecule product

GlobeNewswireMay 17 15:05

Optimistic Buy Rating for Terns Pharmaceuticals Amid Promising Clinical Progress and Solid Financial Footing

TipRanksMay 16 03:38

Analysts Offer Insights on Healthcare Companies: Terns Pharmaceuticals (TERN) and OptimizeRx (OPRX)

TipRanksMay 14 23:30

Buy Rating Affirmed for Terns Pharmaceuticals Amid Robust Financials and Promising Pipeline Prospects

TipRanksMay 14 06:16

HC Wainwright & Co. Reiterates Neutral on Terns Pharma, Maintains $5.5 Price Target

HC Wainwright & Co. analyst Ed Arce reiterates Terns Pharma (NASDAQ:TERN) with a Neutral and maintains $5.5 price target.

BenzingaMay 14 05:34

Hold Rating on Terns Pharmaceuticals Pending Clinical Trial Outcomes

TipRanksMay 14 05:28

Analysts Are Bullish on These Healthcare Stocks: Alphatec Holdings (ATEC), Terns Pharmaceuticals (TERN)

TipRanksMay 13 17:20

Terns Pharmaceuticals | 10-Q: Quarterly report

SEC announcementMay 13 15:19 · Announcements

Terns Pharmaceuticals Shares Are Trading Higher After the Company Reported Better-than-expected Q1 GAAP EPS Results.

Terns Pharmaceuticals Shares Are Trading Higher After the Company Reported Better-than-expected Q1 GAAP EPS Results.

BenzingaMay 13 09:18

Terns Pharmaceuticals Inc (TERN) Q1 2024 Earnings: Misses Analyst Net Loss Projections

Yahoo FinanceMay 13 08:32

Terns Pharma Q1 2024 GAAP EPS $(0.30) Beats $(0.34) Estimate

Terns Pharma (NASDAQ:TERN) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate of $(0.34) by 11.76 percent.

BenzingaMay 13 07:14

Terns Pharmaceuticals 1Q Loss $22.4M >TERN

Terns Pharmaceuticals 1Q Loss $22.4M >TERN

Dow JonesMay 13 07:05

Terns Pharmaceuticals 1Q Loss/Shr 30c >TERN

Terns Pharmaceuticals 1Q Loss/Shr 30c >TERN

Dow JonesMay 13 07:05

Press Release: Terns Pharmaceuticals Reports First Quarter 2024 Financial Results and Corporate Updates

Terns Pharmaceuticals Reports First Quarter 2024 Financial Results and Corporate Updates Interim data from initial dose escalation cohorts from Phase 1 CARDINAL trial of TERN-701 (allosteric BCR-ABL)

Dow JonesMay 13 07:05

Terns Pharmaceuticals Announces Leadership Changes

FOSTER CITY, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. ("Terns" or the "Company") (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of smal

GlobeNewswireMay 8 15:05